Egis Pharmaceuticals Plc Is A Leading Pharmaceutical Company In Central Eastern Europepart Of The Servier Groupwhich Is Based In Francethe Company Operates In 103 Countries And Has Subsidiaries And Offices In 18 Countriesfor The 2023 2024 Financial Yearegis Reported Net Sales Of A 692 7 Million Egis Manages The Entire Pharmaceutical Value Chainincluding Research And Developmentactive Pharmaceutical Ingredientapiproductionfinished Product Manufacturingand Global Distributionthe Company Offers A Diverse Portfolio Of 652 Products Across 170 Product Linesfocusing On Therapeutic Areas Such As Cardiovascular Diseasescentral Nervous System Disordersdiabetologydermatologyand Wound Careegis Is Also Known For Its Biosimilarshaving Launched Several Eu Approved Biosimilar Drugsthe Company Emphasizes Innovative Technologies And Quality Control In Its Manufacturing Processesensuring Cost Efficient Generic Formulations And Complex Api Synthesisegis Is Committed To Healthcare Accessibility And Community Development Through Scientific Collaborationsmedical Education Programsand Social Initiatives
